Cargando…
Pneumocystis jirovecii Pneumonia (PCP) in a Non-HIV Lung Cancer Patient in the Absence of Common Risk Factors
Pneumocystis jirovecii pneumonia (PCP) has been described mainly in AIDs and in immunocompromised patients with hematological malignancies, organ transplant recipients, collagen vascular disease, and primary immune deficiencies or those under treatment with steroids or chemotherapy. The incidence of...
Autores principales: | Hashmi, Shahnawaz, Yousuf, Dawood, Kumar, Prasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583734/ https://www.ncbi.nlm.nih.gov/pubmed/37859870 http://dx.doi.org/10.7759/cureus.45458 |
Ejemplares similares
-
Acute Pneumocystis jirovecii Pneumonia Due to Absolute Lymphopenia
por: Hilker, Eric, et al.
Publicado: (2022) -
Pneumocystis jirovecii Pneumonia in a Patient With Newly Diagnosed HIV and a High CD4 Count
por: Koifman, Michelle, et al.
Publicado: (2023) -
Massive Cavitation by Pneumocystis jirovecii in an Immunocompromised Patient
por: Chaar-Hernandez, Aldair, et al.
Publicado: (2022) -
Pneumocystis jirovecii pneumonia (PCP) PCR-negative conversion predicts prognosis of HIV-negative patients with PCP and acute respiratory failure
por: Choi, Ji Soo, et al.
Publicado: (2018) -
A Rare Case of Pneumocystis Pneumonia in HIV Patient on Glucocorticoid
por: Rehman, Usama, et al.
Publicado: (2021)